Creates new biomedical research innovation agency

Bill hr5585-117 ("Creates new biomedical research innovation agency") is before Congress and has not been decided.

Congress file hr5585-117, before Congress. No action in 1609 days as of 2022-06-22.

What it does

Faster pathway to experimental treatments and cures ARPA-H will fund unconventional medical research projects and coordinate with FDA and Medicare to accelerate development and coverage of breakthrough treatments, potentially bringing cures to patients years sooner than traditional grant processes.

The bigger picture

Shift in how federal health dollars fund innovation By creating a separate agency with independent budget authority and flexible funding mechanisms (grants, prizes, partnerships), ARPA-H will pull resources and focus away from traditional NIH-funded research toward riskier, mission-driven health challenges.

Official summary

Advanced Research Projects Agency-Health Act or the ARPA-H Act This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate health and medical innovation by investing in high-risk, high-reward research. The bill also establishes a committee to advise on agency activities. HHS must transfer all authorities, functions, funds, and personnel from a similar entity within the National Institutes of Health to a new, independent agency. Additionally, the President must appoint a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies. The director must appoint personnel to administer the agency's research programs, including by selecting projects to support and making recommendations about terminating or continuing projects. The agency may use grants, prize competitions, and a variety of other mechanisms to support the research projects. The agency's budget is separate from that of HHS. The agency must coordinate with the Food and Drug Administration and the Centers for Medicare & Medicaid

How they voted

Yes (228)

No (64)

Did not vote / other (4)

Read the official record for hr5585-117

See everything up for a vote · This week in Congress · See what we have filed with the clerk